deferoxamine and hydrazine

deferoxamine has been researched along with hydrazine in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (41.67)	18.2507
2000's	4 (33.33)	29.6817
2010's	3 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glen, RC; Lowe, R; Mitchell, JB	1
Kennedy, CH; Mason, RP; Rumyantseva, GV	1
Avramovici-Grisaru, S; Iheanacho, EN; Samuni, A; Sarel, S; Spira, DT	1
Bergeron, RJ; Evans, KM; Jenny, HB; Luchetta, G; Peter, H; Streiff, RR; Vinson, JR; Wiegand, J	1
Calzada, C; Lagarde, M; Vericel, E	1
Grisham, MB; Koyama, S; Robbins, RA; Sato, E; Simpson, KL	2
Brüne, B; Fandrey, J; Sandau, KB	1
Bernhardt, PV; Chin, P; Richardson, DR; Sharpe, PC; Wang, JY	1
Leitch, HA; Vickars, LM	1
Bastian, TW; Chen, MJ; Connor, JR; Duck, KA; Georgieff, MK; Lanier, LM; Liu, ZJ; Michalopoulos, GC; Sola-Visner, MC	1
Chen, YL; Cooper, N; Garbowski, M; Hider, R; Koonyosying, P; Porter, J; Psaila, B; Sola-Visner, M; Vlachodimitropoulou, E	1

Reviews

1 review(s) available for deferoxamine and hydrazine

Article	Year
Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron? Hematology. American Society of Hematology. Education Program, 2009 Topics: Aged; Anemia; Benzoates; Blood Component Transfusion; Chelation Therapy; Combined Modality Therapy; Deferoxamine; Hematopoietic Cell Growth Factors; Humans; Hydrazines; Iron; Iron Chelating Agents; Iron Overload; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Off-Label Use; Phlebotomy; Practice Guidelines as Topic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoietin	2009

Article

Year

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Hematology. American Society of Hematology. Education Program, 2009

Topics: Aged; Anemia; Benzoates; Blood Component Transfusion; Chelation Therapy; Combined Modality Therapy; Deferoxamine; Hematopoietic Cell Growth Factors; Humans; Hydrazines; Iron; Iron Chelating Agents; Iron Overload; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Off-Label Use; Phlebotomy; Practice Guidelines as Topic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombocytopenia; Thrombopoietin

2009

Other Studies

11 other study(ies) available for deferoxamine and hydrazine

Article	Year
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Trace transition metal-catalyzed reactions in the microsomal metabolism of alkyl hydrazines to carbon-centered free radicals. The Journal of biological chemistry, 1991, Nov-15, Volume: 266, Issue:32 Topics: Animals; Catalase; Chelating Agents; Deferoxamine; Electron Spin Resonance Spectroscopy; Free Radicals; Hydrazines; Kinetics; Male; Microsomes, Liver; Nitrogen Oxides; Phenelzine; Pyridines; Rats; Rats, Inbred Strains; Spin Labels; Structure-Activity Relationship; Superoxide Dismutase	1991
Growth inhibition of Plasmodium falciparum involving carbon centered iron-chelate radical (L., X-)-Fe(III) based on pyridoxal-betaine. A novel type of antimalarials active against chloroquine-resistant parasites. Free radical research communications, 1991, Volume: 15, Issue:1 Topics: Animals; Antimalarials; Chloroquine; Deferoxamine; Drug Resistance; Electron Spin Resonance Spectroscopy; Hydrazines; Iron; Iron Chelating Agents; Molecular Structure; Oxidants; Oxidation-Reduction; Plasmodium falciparum; Spectrophotometry	1991
A comparative evaluation of iron clearance models. Annals of the New York Academy of Sciences, 1990, Volume: 612 Topics: Animals; Bile; Chelating Agents; Deferoxamine; Dihydropyridines; Haplorhini; Hydrazines; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Thiazoles	1990
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. The Biochemical journal, 1997, Jul-15, Volume: 325 ( Pt 2) Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acid; Aspirin; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Deferoxamine; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Hydrazines; Hydrogen Peroxide; Leukotrienes; Lipid Peroxides; Oligopeptides; Peroxides; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; tert-Butylhydroperoxide; Thromboxane B2; Vitamin E	1997
Effects of reactive oxygen and nitrogen metabolites on RANTES- and IL-5-induced eosinophil chemotactic activity in vitro. The American journal of pathology, 1999, Volume: 155, Issue:2 Topics: Chemokine CCL5; Chemotaxis; Deferoxamine; Dithiothreitol; Dose-Response Relationship, Drug; Eosinophils; Humans; Hydrazines; Interleukin-5; Leukotriene B4; Molsidomine; Nitrates; Nitric Oxide; Nitrogen; Pteridines; Reactive Oxygen Species; Superoxides; Tyrosine; Xanthine	1999
Inhibition of MIP-1alpha-induced human neutrophil and monocyte chemotactic activity by reactive oxygen and nitrogen metabolites. The Journal of laboratory and clinical medicine, 2000, Volume: 135, Issue:2 Topics: Chemokine CCL3; Chemokine CCL4; Chemotaxis, Leukocyte; Complement System Proteins; Deferoxamine; Humans; Hydrazines; In Vitro Techniques; Leukotriene B4; Macrophage Inflammatory Proteins; Molsidomine; Monocytes; Neutrophils; Nitrates; Nitric Oxide; Nitric Oxide Donors; Oxidants	2000
Accumulation of HIF-1alpha under the influence of nitric oxide. Blood, 2001, Feb-15, Volume: 97, Issue:4 Topics: Animals; Benzoates; Cell Hypoxia; Cell Line; Cobalt; Coculture Techniques; Deferoxamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Enzyme Inhibitors; Gene Expression Regulation; Glutathione; Guanylate Cyclase; Hydrazines; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Imidazoles; Inflammation; Kidney Tubules, Proximal; Macrophage Activation; Macrophages; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrogen Oxides; Nitroso Compounds; Nuclear Proteins; Oxadiazoles; Oxazines; S-Nitrosoglutathione; Spermine; Swine; Transcription Factors	2001
Novel diaroylhydrazine ligands as iron chelators: coordination chemistry and biological activity. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2005, Volume: 10, Issue:7 Topics: Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Deferoxamine; Drug Screening Assays, Antitumor; Electrochemistry; Humans; Hydrazines; Iron; Iron Chelating Agents; Iron Radioisotopes; Ligands; Lipids; Models, Molecular; Potentiometry; Solutions; Structure-Activity Relationship; Transferrin	2005
Eltrombopag, a thrombopoietin mimetic, crosses the blood-brain barrier and impairs iron-dependent hippocampal neuron dendrite development. Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:3 Topics: Anemia, Iron-Deficiency; Animals; Benzoates; Biological Transport; Biomimetics; Blood-Brain Barrier; Cattle; Chelating Agents; Deferoxamine; Dendrites; Green Fluorescent Proteins; Hippocampus; Hydrazines; Iron; Mice; Microcirculation; Neuroglia; Neurons; Pyrazoles; Thrombocytopenia; Thrombopoietin	2017
Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator. Blood, 2017, 10-26, Volume: 130, Issue:17 Topics: Animals; Benzoates; Cell Line, Tumor; Deferoxamine; Extracellular Space; Ferritins; Hepatocytes; Humans; Hydrazines; Insulin; Insulin Secretion; Insulin-Secreting Cells; Iron; Iron Chelating Agents; Myocytes, Cardiac; Pyrazoles; Pyridones; Rats; Reactive Oxygen Species	2017